A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials

Brain and Behavior

Volumn 3, Issue 6, 2013, Pages 738-746

  Stein, Dan J ^a   Rothbaum, Barbara O ^b   Baldwin, David S ^a,c   Szumski, Annette ^d   Pedersen, Ronald ^d   Davidson, Jonathan R T ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d PFIZER INC   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DSM; Factor analysis; Posttraumatic stress disorder; Venlafaxine

Indexed keywords

PLACEBO; SERTRALINE; VENLAFAXINE;

ADULT; ANALYSIS OF COVARIANCE; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; CLINICIAN ADMINISTERED PTSD SCALE; COGNITION; COMPARATIVE STUDY; CONFIRMATORY FACTORIAL ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFICACY; DRUG RESPONSE; DSM-5; DSM-IV; EXPLORATORY FACTORIAL ANALYSIS; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MULTICENTER STUDY (TOPIC); PEARSON CORRELATION MATRIX; POLYCHORIC CORRELATION COVARIANCE MATRIX; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SYMPTOM ASSESSMENT; TREATMENT OUTCOME;

EID: 84893488648     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.183     Document Type: Article

References (29)

1. Amdur, R. L., and I. Liberzon. 2001. The structure of posttraumatic stress disorder symptoms in combat veterans: a confirmatory factor analysis of the impact of event scale. J. Anxiety Disord. 15:345-357.
2. American Psychiatric Association. 1994. Pp. 424-429 in Posttraumatic stress disorder. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). American Psychiatric Association, Washington, DC.
3. Asmundson, G. J., I. Frombach, J. McQuaid, P. Pedrelli, R. Lenox, and M. B. Stein, et al. 2000. Dimensionality of posttraumatic stress symptoms: a confirmatory factor analysis of DSM-IV symptom clusters and other symptom models. Behav. Res. Ther. 38:203-214.
4. Baschnagel, J. S., R. M. O'Connor, C. R. Colder, and L. W. Hawk Jr. 2005. Factor structure of posttraumatic stress among Western New York undergraduates following the September 11th terrorist attack on the World Trade Center. J. Trauma. Stress 18:677-684.
5. Blake, D. D., F. W. Weathers, L. M. Nagy, D. G. Kaloupek, F. D. Gusman, D. S. Charney, et al. 1995. The development of a Clinician-Administered PTSD Scale. J. Trauma. Stress 8:75-90.
6. Buckley, T. C., E. B. Blanchard, and E. J. Hickling. 1998. A confirmatory factor analysis of posttraumatic stress symptoms. Behav. Res. Ther. 36:1091-1099.
7. Charney, D. S., A. Y. Deutch, J. H. Krystal, S. M. Southwick, and M. Davis. 1993. Psychobiologic mechanisms of posttraumatic stress disorder. Arch. Gen. Psychiatry 50:295-305.
8. Committee on Treatment of Posttraumatic Stress Disorder. 2008. Treatment of posttraumatic stress disorder: an assessment of the evidence. The National Academies Press, Washington, DC.
9. Davidson, J. R. 2006. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J. Clin. Psychiatry 67(Suppl. 2):34-39.
10. Davidson, J., D. Baldwin, D. J. Stein, E. Kuper, I. Benattia, S. Ahmed et al. 2006a. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch. Gen. Psychiatry 63:1158-1165.
11. Davidson, J., B. O. Rothbaum, P. Tucker, G. Asnis, I. Benattia, and J. J. Musgnung. 2006b. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J. Clin. Psychopharmacol. 26:259-267.
12. Elhai, J. D., J. D. Ford, K. J. Ruggiero, and B. Christopher Frueh. 2009. Diagnostic alterations for post-traumatic stress disorder: examining data from the National Comorbidity Survey Replication and National Survey of Adolescents. Psychol. Med. 39:1957-1966.
13. Fabrigar, L. R., P. S. Visser, and M. W. Browne. 1997. Conceptual and methodological issues in testing the circumplex structure of data in personality and social psychology. Pers. Soc. Psychol. Rev. 1:184-203.
14. Fabrigar, L. R., D. T. Wegener, R. C. MacCallum, and E. J. Strahan. 1999. Evaluating the use of exploratory factor analysis in psychological research. Psychol. Methods 4:272-299.
15. Foa, E. B., D. S. Riggs, and B. S. Gershuny. 1995. Arousal, numbing, and intrusion: symptom structure of PTSD following assault. Am. J. Psychiatry 152:116-120.
16. Friedman, M. J., P. A. Resick, R. A. Bryant, and C. R. Brewin. 2011. Considering PTSD for DSM-5. Depress. Anxiety 28:750-769.
17. Gaffney, M. 2003. Factor analysis of treatment response in posttraumatic stress disorder. J. Trauma. Stress 16:77-80.
18. Horowitz, M., N. Wilner, and W. Alvarez. 1979. Impact of Event Scale: a measure of subjective stress. Psychosom. Med. 41:209-218.
19. Hu, L.-T., and P. Bentler. 1999. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equ. Model. 6:1-55.
20. King, D. W., G. A. Leskin, L. A. King, and F. W. Weathers 1998. Confirmatory factor analysis of the clinician-administered PTSD scale: evidence for the dimensionality of posttraumatic stress disorder. Psychol. Assess. 10:90-96.
21. Mataix-Cols, D., S. L. Rauch, P. A. Manzo, M. A. Jenike, and L. Baer. 1999. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am. J. Psychiatry 156:1409-1416.
22. McWilliams, L. A., B. J. Cox, and G. J. Asmundson. 2005. Symptom structure of posttraumatic stress disorder in a nationally representative sample. J. Anxiety Disord. 19:626-641.
23. National Institute for Clinical Excellence. 2005. Pp. 1-41 in Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care. Clinical Guideline 26. National Collaborating Centre for Mental Health, London, U.K.
24. Newport, D. J., and C. B. Nemeroff. 2000. Neurobiology of posttraumatic stress disorder. Curr. Opin. Neurobiol. 10:211-218.
25. North, C. S., A. M. Suris, M. Davis, and R. P. Smith. 2009. Toward validation of the diagnosis of posttraumatic stress disorder. Am. J. Psychiatry 166:34-41.
26. Stein, D. J., E. W. Andersen, and M. Lader. 2006a. Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions. Eur. Neuropsychopharmacol. 16:33-38.
27. Stein, D. J., J. C. Ipser, and S. Seedat. 2006b. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst. Rev. 25:CD002795.
28. Stein, D. J., E. W. Andersen, and K. F. Overo. 2007. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Rev. Bras. Psiquiatr. 29:303-307.
29. Stein, D. J., R. Pedersen, B. O. Rothbaum, D. S. Baldwin, S. Ahmed, J. Musgnung, et al. 2009. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. Int. J. Neuropsychopharmacol. 12:23-31.